Welcome to our dedicated page for Donaldson news (Ticker: DCI), a resource for investors and traders seeking the latest updates and insights on Donaldson stock.
Donaldson Inc (NYSE: DCI), a global leader in filtration systems and solutions, provides critical updates through this dedicated news hub. Investors and industry professionals will find authoritative coverage of corporate developments, including earnings announcements, product innovations, and strategic partnerships.
This resource serves as a comprehensive repository for all official communications and market-relevant updates. Users can expect timely information on quarterly financial results, new filtration technology launches, and sustainability initiatives, along with analysis of operational milestones across DCI's mobile, industrial, and life sciences divisions.
Key updates include developments in advanced air/liquid purification systems, industrial equipment efficiency improvements, and cross-sector engineering collaborations. The curated content enables stakeholders to track DCI's progress in addressing complex filtration challenges through its patented technologies.
Bookmark this page for direct access to verified information about Donaldson's market leadership in engineered filtration solutions. Check regularly for updates that impact long-term value creation in essential industries from transportation to pharmaceuticals.
Donaldson and PolyPeptide have partnered to enhance sustainability in peptide manufacturing by developing a solvent recovery system for peptide purification. Leveraging Donaldson's filtration expertise and PolyPeptide's peptide synthesis skill, the technology reclaims and purifies acetonitrile, significantly reducing solvent consumption and waste. The system, piloted at PolyPeptide's Torrance site, reduces environmental impact by reclaiming solvents typically incinerated post-use. This collaboration aligns with both companies' commitment to sustainable manufacturing and green chemistry principles.
Donaldson Company, Inc. (NYSE: DCI) is developing an integrated upstream and downstream platform for viral vector manufacturing, focusing on lentivirus (LV) production to improve recoveries and reduce manufacturing complexity. The platform aims to accelerate process development timelines and lower costs in the production of cell and gene therapies. Univercells Technologies and Isolere Bio are collaborating on this initiative, with Isolere's IsoTag LV affinity purification reagent offering high functional recoveries and purity, while Univercells Technologies' scale-X bioreactor demonstrates high yields of LV in perfusion mode. The project is a strategic move by Donaldson to enhance its presence in the bioprocessing space through innovative acquisitions.
Donaldson Company, Inc. (NYSE: DCI) will present at the Oppenheimer 19th Annual Industrial Growth Conference on May 6, 2024. The CFO, Scott Robinson, will represent the company at 12:00 p.m. ET. The presentation can be accessed via live webcast on the company's Investor Relations website. Donaldson is a technology-led filtration products provider, serving various industries globally.
Donaldson Company, Inc. (NYSE: DCI) will webcast its third-quarter 2024 earnings conference call on June 4, 2024, at 9:00 a.m. CT. The webcast replay will be available on the company's Investor Relations website. Donaldson, founded in 1915, is a global leader in filtration products serving various industries.
FAQ
What is the current stock price of Donaldson (DCI)?
What is the market cap of Donaldson (DCI)?
